fda warning bpc-157 unapproved peptide 2024 2025 Compliance for Therapy and – Holt Law A FDA panel is weighing

Each product is sterile, pharmaceutical-grade, and third-party tested for safety, potency, and purity

Studies suggest that oral BPC-157 interacts with the nitric oxide system, VEGF signaling, and growth factor receptor pathways in gastrointestinal tissue

Neural Regeneration Research, 17 (3), 482

UK REACH and Workplace Controls Where a peptide is lawfully handled as a laboratory chemical, additional duties may arise under chemical and workplace frameworks

This product is third-party lab tested with a verifiable Certificate of Analysis in every box: sterile, non-pyrogenic, 0.9% benzyl alcohol, confirmed for the exact lot

Quick answer Across documented research protocols, the 10 mg BPC-157 vial is commonly reconstituted with 3 mL of bacteriostatic water, with the research literature referencing approximately 300 mcg per dose measured from that solution